Breast Cancer Clinical Trial
— STIVIOfficial title:
Pilot RCT on Lifestyles Impact on Health Outcomes in the General Population Invited to Mammography and Colorectal Cancer Screening Programmes. (STI.li di VI.ta - Lifestyles) STI.VI.
Verified date | April 2017 |
Source | Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The main study objective is to determine the feasibility and impact (effectiveness) of
intervention models for lifestyle changing (diet and physical activity) on health outcomes.
Women 50 to 54-year-old attending the local breast cancer screening and 58-year-old people
(both sexes) undergoing colorectal cancer screening are invited to participate in the study.
Compliers are randomized into 3 intervention groups (Diet, Physical Activity, and Physical
Activity and Diet) and into the 'usual care' Control group. Biological sampling (blood and
saliva) is collected from all participants. All participants undergo also anthropometric
measurements and fill in a self-administered validated questionnaire on their dietary and
physical activity habits. All enrolled subjects receive a booklet with basic information
about diet and physical activity. Subjects randomized to the 3 intervention groups are also
offered one theoretical and three training courses. The courses are specifically designed
for the different interventions proposed and aimed at reinforcing the educational counseling
and at supporting behavioral changes.
Follow-up is performed at 8 (intermediate follow-up) and 12-14 (final follow-up) months for
repeating anthropometric measurements and questionnaire filling and blood sampling (at the
final one).
Status | Completed |
Enrollment | 1270 |
Est. completion date | June 2014 |
Est. primary completion date | January 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 49 Years to 61 Years |
Eligibility |
Inclusion Criteria: - 49 to 55-year-old women invited to mammography screening, - 58 to 61 year-old people (both sexes) invited to colorectal screening Exclusion Criteria: - psychiatric disorders, - disabling disease - life expectancy <6 months - eating or deambulation disorders - in physiotherapy at the time of recruitment. |
Country | Name | City | State |
---|---|---|---|
Italy | S.C.D.O. Epidemiologia dei Tumori - Azienda Ospedaliera S. Giovanni Battista di Torino | Torino | Piedmont |
Lead Sponsor | Collaborator |
---|---|
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte | Azienda Sanitaria Locale Torino 1 |
Italy,
Anderson AS, Mackison D, Boath C, Steele R. Promoting changes in diet and physical activity in breast and colorectal cancer screening settings: an unexplored opportunity for endorsing healthy behaviors. Cancer Prev Res (Phila). 2013 Mar;6(3):165-72. doi: 10.1158/1940-6207.CAPR-12-0385. Epub 2013 Jan 16. Review. — View Citation
Assfalg M, Bertini I, Colangiuli D, Luchinat C, Schäfer H, Schütz B, Spraul M. Evidence of different metabolic phenotypes in humans. Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1420-4. doi: 10.1073/pnas.0705685105. Epub 2008 Jan 29. — View Citation
McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res. 2003 Apr;18(2):156-70. — View Citation
Robb KA, Power E, Kralj-Hans I, Atkin WS, Wardle J. The impact of individually-tailored lifestyle advice in the colorectal cancer screening context: a randomised pilot study in North-West London. Prev Med. 2010 Dec;51(6):505-8. doi: 10.1016/j.ypmed.2010.10.002. Epub 2010 Oct 13. — View Citation
Steindorf K, Ritte R, Eomois PP, Lukanova A, Tjonneland A, Johnsen NF, Overvad K, Østergaard JN, Clavel-Chapelon F, Fournier A, Dossus L, Teucher B, Rohrmann S, Boeing H, Wientzek A, Trichopoulou A, Karapetyan T, Trichopoulos D, Masala G, Berrino F, Mattiello A, Tumino R, Ricceri F, Quirós JR, Travier N, Sánchez MJ, Navarro C, Ardanaz E, Amiano P, Bueno-de-Mesquita HB, van Duijnhoven F, Monninkhof E, May AM, Khaw KT, Wareham N, Key TJ, Travis RC, Borch KB, Sund M, Andersson A, Fedirko V, Rinaldi S, Romieu I, Wahrendorf J, Riboli E, Kaaks R. Physical activity and risk of breast cancer overall and by hormone receptor status: the European prospective investigation into cancer and nutrition. Int J Cancer. 2013 Apr 1;132(7):1667-78. doi: 10.1002/ijc.27778. Epub 2012 Sep 14. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | feasibility outcome | initial participation rate overall and stratified by intervention group, age, and gender; | 14 months | |
Primary | impact of intervention model | compliance to lifestyle recommendations and their maintenance assessed through the STI.VI. questionnaire; | 14 months | |
Primary | impact of intervention model | changes in anthropometric measurements | 14 months | |
Primary | impact of intervention model | comparison of metabolic parameters (insulin, glucose, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, IGF-1, testosterone) | 14 months | |
Primary | impact of intervention model | evaluation of potential genetic and/or metabolic biomarkers in cancer development; | 14 months | |
Primary | screening-related indicators | screening participation rate in subjects enrolled in the STI.VI. study and, viceversa, STI.VI. participation rate in screened subjects; | up to 10 years after study end | |
Primary | screening-related indicators | evaluation of breast and colorectal screening outcomes among STI.VI. participants | up to 10 years after study end | |
Secondary | Biobank implementation | number of blood sample and saliva sample cryopreserved at baseline and at final follow up | up to 10 years after study end | |
Secondary | Circulating biomarkers association with breast and colorectal cancer | investigate whether selected circulating miRNAs previously found associated to brast and colorectal risk are significantly altered in the plasma of cancer patients compared to matched healthy controls and if they satisfy pre-specified true- and false positive rates that are considered minimally acceptable in the screening setting. | up to 10 years after study end |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |